Koers Rekah Pharmaceutical Industry Ltd. TEL AVIV STOCK EXCHANGE
Aandelen
REKA
IL0010810096
Farmaceutische producten
Omzet 2022 | 292 mln. 78,75 mln. 72,94 mln. | Omzet 2023 | 322 mln. 86,63 mln. 80,25 mln. | Marktkapitalisatie | 169 mln. 45,44 mln. 42,09 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2022 | -2 mln. -539K -499K | Nettowinst (verlies) 2023 | -6 mln. -1,62 mln. -1,5 mln. | EV/omzet 2022 | 1,1 x |
Nettoschuld 2022 | 145 mln. 39,16 mln. 36,28 mln. | Nettoschuld 2023 | 166 mln. 44,83 mln. 41,52 mln. | EV/omzet 2023 | 1,04 x |
K/w-verhouding 2022 |
-85,5
x | K/w-verhouding 2023 |
-24,2
x | Werknemers | - |
Dividendrendement 2022 * |
-
| Dividendrendement 2023 |
-
| Vrij verhandelbaar | 17,36% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Chief Executive Officer | 80 | 24-08-93 | |
Yuval Bernshtein
DFI | Director of Finance/CFO | 44 | 01-11-18 |
Director/Board Member | 78 | 24-08-93 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Ishay Davidi
BRD | Director/Board Member | 62 | 15-04-15 |
Amiram Boehm
BRD | Director/Board Member | 52 | 15-04-15 |
Avraham Bigger
CHM | Chairman | 77 | 15-04-15 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+21,07% | 72,78 mld. | |
-1,10% | 24,24 mld. | |
+8,80% | 8,59 mld. | |
+8,25% | 8,38 mld. | |
-19,42% | 8,09 mld. | |
+6,65% | 4,81 mld. | |
+16,83% | 4,32 mld. | |
-1,83% | 4,05 mld. | |
+26,97% | 3,79 mld. |